44 related articles for article (PubMed ID: 15980977)
1. Cranial and Spinal Oligodendrogliomatosis: A Case Report and Review of the Literature.
Erdogan K; Mammadkhanli O; Dogan I; Ersoz CC; Okcu AH; Unlu MA
Asian J Neurosurg; 2021; 16(3):626-629. PubMed ID: 34660384
[TBL] [Abstract][Full Text] [Related]
2. Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases.
Bae JW; Hong EK; Gwak HS
Brain Tumor Res Treat; 2017 Oct; 5(2):99-104. PubMed ID: 29188211
[TBL] [Abstract][Full Text] [Related]
3. Primary diffuse leptomeningeal oligodendrogliomatosis: A case report and literature review.
Chellathurai A; Vaidya JS; Kathirvelu G; Alagappan P
Indian J Radiol Imaging; 2016; 26(3):337-341. PubMed ID: 27857459
[TBL] [Abstract][Full Text] [Related]
4. Primary diffuse leptomeningeal gliomatosis as a rare cause of pain in cervical spine.
Sivák Š; Kantorová E; Kurča E; Marcinek J; Slávik P; Michalik J; Nosáľ V
BMC Cancer; 2016 Mar; 16():182. PubMed ID: 26944049
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors.
Segura PP; Gil M; Balañá C; Chacón I; Langa JM; Martín M; Bruna J
J Neurooncol; 2012 Aug; 109(1):137-42. PubMed ID: 22610937
[TBL] [Abstract][Full Text] [Related]
6. A case of primary leptomeningeal gliomatosis confined to the spinal cord.
Bhatia R; Roncaroli F; Thomas P; Cheah SL; Mehta A; Glaser M; Ulbricht C
J Neurooncol; 2010 May; 98(1):125-9. PubMed ID: 19898776
[TBL] [Abstract][Full Text] [Related]
7. Primary diffuse leptomeningeal gliosarcomatosis.
Watanabe Y; Hotta T; Yoshioka H; Itou Y; Taniyama K; Sugiyama K
J Neurooncol; 2008 Jan; 86(2):207-10. PubMed ID: 17628746
[TBL] [Abstract][Full Text] [Related]
8. A case report and review of the literature.
Yomo S; Tada T; Hirayama S; Tachibana N; Otani M; Tanaka Y; Hongo K
J Neurooncol; 2007 Jan; 81(2):209-16. PubMed ID: 17031563
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
[TBL] [Abstract][Full Text] [Related]
10. Current and future developments in the use of temozolomide for the treatment of brain tumours.
Stupp R; Gander M; Leyvraz S; Newlands E
Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis.
Franceschi E; Cavallo G; Scopece L; Esposti RD; Paioli G; Paioli A; Palmerini E; Foschini MP; Marliani AF; Crinò L
J Neurooncol; 2005 Jul; 73(3):261-4. PubMed ID: 15980977
[TBL] [Abstract][Full Text] [Related]
12. Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review.
Hansen N; Wittig A; Hense J; Kastrup O; Gizewski ER; Van de Nes JA
Eur J Med Res; 2011 Sep; 16(9):415-9. PubMed ID: 22024443
[TBL] [Abstract][Full Text] [Related]
13. Primary diffuse leptomeningeal gliomatosis in children: a clinical pathologic correlation.
Bernardini FP; Croxatto JO; Nozza P; Rossi A; Capris P
Ophthalmic Plast Reconstr Surg; 2013; 29(2):93-7. PubMed ID: 23247038
[TBL] [Abstract][Full Text] [Related]
14. Case of primary diffuse leptomeningeal gliomatosis.
Yamasaki K; Yokogami K; Ohta H; Yamashita S; Uehara H; Sato Y; Takeshima H
Brain Tumor Pathol; 2014 Jul; 31(3):177-81. PubMed ID: 24473978
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
